VC
Vivek Chhachhi
About Vivek Chhachhi
Data last updated:
Vivek Chhachhi is a Director at Dcm Nouvelle Limited (since 2021), Director at Sekhmet Pharmaventures Private Limited (since 2020) and Nominee Director at Veeda Clinical Research Limited (since 2018), and holds 4 more current directorships. The companies operate in Manufacturing, Pharma and Healthcare. The 7 current companies with reported revenue have a combined latest revenue of ₹3,270 Cr; the largest is Dcm Nouvelle Limited at ₹1,082 Cr (FY 2025). Earlier, Vivek Chhachhi was a Director at Natco Pharma Limited (2014–2018) and Alternate Director at Jai Balaji Industries Limited (2008) and 11 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dcm Nouvelle Limited L17309DL2016PLC307204 | Director | 01 Apr 2021 | 2016 | ₹1,082 Cr (FY 2025) | Active |
 Sekhmet Pharmaventures Private Limited U74999MH2020PTC340954 | Director | 04 Dec 2020 | 2020 | ₹1,064 Cr (FY 2025) | Active |
 Veeda Clinical Research Limited U73100GJ2004PLC044023 | Nominee Director | 21 Nov 2018 | 2004 | ₹621 Cr (FY 2025) | Active |
 Anjan Drug Private Limited U24231TN1990PTC019461 | Nominee Director | 09 Oct 2020 | 1990 | ₹293 Cr (FY 2025) | Active |
 Sabine Hospital & Research Centre Private Limited U74999KL2016PTC046936 | Nominee Director | 06 Jun 2024 | 2016 | ₹166 Cr (FY 2025) | Active |
 Cx Advisors Llp AAA-4311 | Designated Partner | 31 Mar 2011 | 2011 | ₹26.08 Cr (FY 2021) | Active |
| Dcm Nouvelle Specialty Chemicals Limited U24290DL2022PLC393180 | Director | 02 Feb 2022 | 2022 | ₹17.63 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Natco Pharma Limited L24230TG1981PLC003201 | Director | 27 Sep 2014 | 1981 | ₹4,784 Cr (FY 2025) | Active |
 Jai Balaji Industries Limited L27102WB1999PLC089755 | Alternate Director | 07 Feb 2008 | 1999 | ₹5,821 Cr (FY 2026) | Active |
 Himadri Speciality Chemical Limited L27106WB1987PLC042756 | Nominee Director | 27 Aug 2008 | 1987 | ₹4,832 Cr (FY 2026) | Active |
 Spml Infra Limited L40106WB1981PLC276372 | Alternate Director | 21 Aug 2007 | 1981 | ₹824 Cr (FY 2025) | Active |
| Techno Electric & Engg Co Ltd L45309WB1963PLC025898 | Nominee Director | 25 Oct 2008 | 1963 | Amalgamated | |
 Clc Industries Limited L74899MH1991PLC457161 | Director | 07 Dec 2006 | 1991 | ₹72.08 Cr (FY 2025) | Active |
 Sis Limited L75230BR1985PLC002083 | Alternate Director | 03 Apr 2013 | 1985 | ₹16,030 Cr (FY 2026) | Active |
 Thyrocare Technologies Limited L86905MH2000PLC123882 | Nominee Director | 27 Dec 2010 | 2000 | ₹702 Cr (FY 2025) | Active |
| Cx Advisors Private Limited U74140DL2008PTC182274 | Whole-Time Director | 05 Jul 2010 | 2008 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vivek Chhachhi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Chhachhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Chhachhi
Vivek Chhachhi currently holds 7 directorships: Dcm Nouvelle Limited (Director, since 01 Apr 2021, revenue ₹1,082 Cr (FY 2025)); Sekhmet Pharmaventures Private Limited (Director, since 04 Dec 2020, revenue ₹1,064 Cr (FY 2025)); Veeda Clinical Research Limited (Nominee Director, since 21 Nov 2018, revenue ₹621 Cr (FY 2025)); Anjan Drug Private Limited (Nominee Director, since 09 Oct 2020, revenue ₹293 Cr (FY 2025)); Sabine Hospital & Research Centre Private Limited (Nominee Director, since 06 Jun 2024, revenue ₹166 Cr (FY 2025)); and 2 more.
Vivek Chhachhi was first appointed on 20 Sep 2000 as Director at Beehive Systems Private Limited. The most recent appointment on record is 06 Jun 2024 at Sabine Hospital & Research Centre Private Limited.
The 7 current companies of Vivek Chhachhi that report revenue have a combined latest revenue of ₹3,270 Cr: Dcm Nouvelle Limited ₹1,082 Cr (FY 2025); Sekhmet Pharmaventures Private Limited ₹1,064 Cr (FY 2025); Veeda Clinical Research Limited ₹621 Cr (FY 2025); Anjan Drug Private Limited ₹293 Cr (FY 2025); Sabine Hospital & Research Centre Private Limited ₹166 Cr (FY 2025); and 2 more.
Vivek Chhachhi held 13 earlier board appointments: Natco Pharma Limited (Director, 27 Sep 2014 to 23 May 2018); Jai Balaji Industries Limited (Alternate Director, 07 Feb 2008 to 01 Aug 2008); Himadri Speciality Chemical Limited (Nominee Director, 27 Aug 2008 to 28 May 2010); Spml Infra Limited (Alternate Director, 21 Aug 2007 to 31 Jul 2008); Techno Electric & Engg Co Ltd (Nominee Director, 25 Oct 2008 to 30 Mar 2009); and 8 more.
The current boards of Vivek Chhachhi's companies include Deepak Sood (Dcm Nouvelle Limited), Hemant Bharat Ram (Dcm Nouvelle Limited), Jitendra Tuli (Dcm Nouvelle Limited), Kulbir Singh (Dcm Nouvelle Limited), Meenakshi Nayar (Dcm Nouvelle Limited), Rajinder Khanna (Dcm Nouvelle Limited), among others.